Citadel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Buy |
653,635
+615,084
| +1,596% | +$17.7M | ﹤0.01% | 998 |
|
|
2025
Q1 | $1.29M | Buy |
38,551
+33,829
| +716% | +$1.13M | ﹤0.01% | 2994 |
|
|
2024
Q4 | $241K | Sell |
4,722
-130,412
| -97% | -$6.67M | ﹤0.01% | 4720 |
|
|
2024
Q3 | $6.91M | Buy |
135,134
+13,255
| +11% | +$677K | ﹤0.01% | 1511 |
|
|
2024
Q2 | $5.46M | Sell |
121,879
-49,545
| -29% | -$2.22M | ﹤0.01% | 1620 |
|
|
2024
Q1 | $8.02M | Buy |
171,424
+148,632
| +652% | +$6.96M | ﹤0.01% | 1424 |
|
|
2023
Q4 | $811K | Sell |
22,792
-136,444
| -86% | -$4.85M | ﹤0.01% | 3243 |
|
|
2023
Q3 | $4.74M | Sell |
159,236
-82,492
| -34% | -$2.45M | ﹤0.01% | 1661 |
|
|
2023
Q2 | $4.36M | Sell |
241,728
-43,867
| -15% | -$790K | ﹤0.01% | 1807 |
|
|
2023
Q1 | $4.59M | Buy |
285,595
+248,239
| +665% | +$3.99M | ﹤0.01% | 1883 |
|
|
2022
Q4 | $684K | Sell |
37,356
-2,855
| -7% | -$52.2K | ﹤0.01% | 3566 |
|
|
2022
Q3 | $790K | Buy |
+40,211
| New | +$790K | ﹤0.01% | 3644 |
|
|
2022
Q2 | – | Sell |
-49,839
| Closed | -$1.09M | – | 6111 |
|
|
2022
Q1 | $1.09M | Sell |
49,839
-14,985
| -23% | -$329K | ﹤0.01% | 3643 |
|
|
2021
Q4 | $1.84M | Buy |
64,824
+27,605
| +74% | +$784K | ﹤0.01% | 3149 |
|
|
2021
Q3 | $783K | Sell |
37,219
-23,439
| -39% | -$493K | ﹤0.01% | 4032 |
|
|
2021
Q2 | $1.14M | Buy |
+60,658
| New | +$1.14M | ﹤0.01% | 3847 |
|
|
2021
Q1 | – | Sell |
-46,864
| Closed | -$661K | – | 6321 |
|
|
2020
Q4 | $661K | Buy |
46,864
+7,762
| +20% | +$109K | ﹤0.01% | 3626 |
|
|
2020
Q3 | $613K | Buy |
39,102
+6,076
| +18% | +$95.3K | ﹤0.01% | 3320 |
|
|
2020
Q2 | $579K | Sell |
33,026
-2,711
| -8% | -$47.5K | ﹤0.01% | 3333 |
|
|
2020
Q1 | $526K | Buy |
35,737
+7,809
| +28% | +$115K | ﹤0.01% | 3361 |
|
|
2019
Q4 | $701K | Buy |
27,928
+295
| +1% | +$7.41K | ﹤0.01% | 3296 |
|
|
2019
Q3 | $416K | Buy |
27,633
+15,839
| +134% | +$238K | ﹤0.01% | 3611 |
|
|
2019
Q2 | $295K | Buy |
+11,794
| New | +$295K | ﹤0.01% | 3880 |
|